PPARGC1A and metabolic dysfunction-associated steatotic liver disease: The goals of this investigation are to (1) elaborate on whether fenofibrate regulates liver lipid accumulation by mediating mitochondrial function, and (2) explore the mechanism of PGC-1α mediated mitochondrial function to regulate lipid accumulation in hepatocytes, and provide theoretical basis and reference for finding new targets for NAFLD treatment.